These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19275599)

  • 1. Bronchial asthma, chronic obstructive pulmonary disease and NF-kappaB.
    Charokopos N; Apostolopoulos N; Kalapodi M; Leotsinidis M; Karamanos N; Mouzaki A
    Curr Med Chem; 2009; 16(7):867-83. PubMed ID: 19275599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcription Factor NF-κB: An Update on Intervention Strategies.
    Panday A; Inda ME; Bagam P; Sahoo MK; Osorio D; Batra S
    Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(6):463-483. PubMed ID: 27236331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NF-kappaB Signaling in Chronic Inflammatory Airway Disease.
    Schuliga M
    Biomolecules; 2015 Jun; 5(3):1266-83. PubMed ID: 26131974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-1β upregulates Muc5ac expression via NF-κB-induced HIF-1α in asthma.
    Wu S; Li H; Yu L; Wang N; Li X; Chen W
    Immunol Lett; 2017 Dec; 192():20-26. PubMed ID: 29031476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the NF-kappaB pathway in asthma and chronic obstructive pulmonary disease.
    Edwards MR; Bartlett NW; Clarke D; Birrell M; Belvisi M; Johnston SL
    Pharmacol Ther; 2009 Jan; 121(1):1-13. PubMed ID: 18950657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Lymphocytes in the Pathogenesis of Asthma and COPD.
    Baraldo S; Lokar Oliani K; Turato G; Zuin R; Saetta M
    Curr Med Chem; 2007; 14(21):2250-6. PubMed ID: 17896974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular and molecular mechanisms in chronic obstructive pulmonary disease: an overview.
    Di Stefano A; Caramori G; Ricciardolo FL; Capelli A; Adcock IM; Donner CF
    Clin Exp Allergy; 2004 Aug; 34(8):1156-67. PubMed ID: 15298554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of nuclear factor-kappaB in inflammatory lung disease.
    Imanifooladi AA; Yazdani S; Nourani MR
    Inflamm Allergy Drug Targets; 2010 Jul; 9(3):197-205. PubMed ID: 20687892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic obstructive pulmonary disease in a new concept.
    Murărescu ED; Mitrofan EC; Mihailovici MS
    Rom J Morphol Embryol; 2007; 48(3):207-14. PubMed ID: 17914487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of nuclear factor kappa B in the pathogenesis of pulmonary diseases: implications for therapy.
    Wright JG; Christman JW
    Am J Respir Med; 2003; 2(3):211-9. PubMed ID: 14720003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective blockade of NF-kappa B activity in airway immune cells inhibits the effector phase of experimental asthma.
    Desmet C; Gosset P; Pajak B; Cataldo D; Bentires-Alj M; Lekeux P; Bureau F
    J Immunol; 2004 Nov; 173(9):5766-75. PubMed ID: 15494529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-inflammatory inhibitors of IkappaB kinase in asthma and COPD.
    Caramori G; Adcock IM; Ito K
    Curr Opin Investig Drugs; 2004 Nov; 5(11):1141-7. PubMed ID: 15573863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rhinovirus replication in human macrophages induces NF-kappaB-dependent tumor necrosis factor alpha production.
    Laza-Stanca V; Stanciu LA; Message SD; Edwards MR; Gern JE; Johnston SL
    J Virol; 2006 Aug; 80(16):8248-58. PubMed ID: 16873280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The function of nuclear factor-erythroid 2-related factor 2 and its association with I-kappa B kinases alpha/beta in a rat model of chronic obstructive pulmonary disease.].
    Li XY; Luo BL; Chen HM
    Zhonghua Jie He He Hu Xi Za Zhi; 2009 Dec; 32(12):935-9. PubMed ID: 20193356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repression of inflammatory gene expression in human pulmonary epithelial cells by small-molecule IkappaB kinase inhibitors.
    Newton R; Holden NS; Catley MC; Oyelusi W; Leigh R; Proud D; Barnes PJ
    J Pharmacol Exp Ther; 2007 May; 321(2):734-42. PubMed ID: 17322026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Future of Biological Therapies in COPD.
    Gea J
    Arch Bronconeumol (Engl Ed); 2018 Apr; 54(4):185-186. PubMed ID: 29291901
    [No Abstract]   [Full Text] [Related]  

  • 17. Validation of the anti-inflammatory properties of small-molecule IkappaB Kinase (IKK)-2 inhibitors by comparison with adenoviral-mediated delivery of dominant-negative IKK1 and IKK2 in human airways smooth muscle.
    Catley MC; Sukkar MB; Chung KF; Jaffee B; Liao SM; Coyle AJ; Haddad el-B; Barnes PJ; Newton R
    Mol Pharmacol; 2006 Aug; 70(2):697-705. PubMed ID: 16687566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IκB kinase-driven nuclear factor-κB activation in patients with asthma and chronic obstructive pulmonary disease.
    Gagliardo R; Chanez P; Profita M; Bonanno A; Albano GD; Montalbano AM; Pompeo F; Gagliardo C; Merendino AM; Gjomarkaj M
    J Allergy Clin Immunol; 2011 Sep; 128(3):635-45.e1-2. PubMed ID: 21571356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemophilus influenzae induces steroid-resistant inflammatory responses in COPD.
    Cosío BG; Jahn A; Iglesias A; Shafiek H; Busquets X; Agustí A
    BMC Pulm Med; 2015 Dec; 15():157. PubMed ID: 26642881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammasome signaling in pathogenesis of lung diseases.
    Mortaz E; Masjedi MR; Allameh A; Adcock IM
    Curr Pharm Des; 2012; 18(16):2320-8. PubMed ID: 22390695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.